Cargando…
Early lung cancer diagnostic biomarker discovery by machine learning methods
Early diagnosis has been proved to improve survival rate of lung cancer patients. The availability of blood-based screening could increase early lung cancer patient uptake. Our present study attempted to discover Chinese patients’ plasma metabolites as diagnostic biomarkers for lung cancer. In this...
Autores principales: | Xie, Ying, Meng, Wei-Yu, Li, Run-Ze, Wang, Yu-Wei, Qian, Xin, Chan, Chang, Yu, Zhi-Fang, Fan, Xing-Xing, Pan, Hu-Dan, Xie, Chun, Wu, Qi-Biao, Yan, Pei-Yu, Liu, Liang, Tang, Yi-Jun, Yao, Xiao-Jun, Wang, Mei-Fang, Leung, Elaine Lai-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683339/ https://www.ncbi.nlm.nih.gov/pubmed/33217646 http://dx.doi.org/10.1016/j.tranon.2020.100907 |
Ejemplares similares
-
The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
por: Li, Run-Ze, et al.
Publicado: (2022) -
Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor
por: Wang, Jian, et al.
Publicado: (2022) -
miR-20b promotes growth of non-small cell lung cancer through a positive feedback loop of the Wnt/β-catenin signaling pathway
por: Ren, Tao, et al.
Publicado: (2019) -
Evodiamine suppresses non-small cell lung cancer by elevating CD8(+) T cells and downregulating the MUC1-C/PD-L1 axis
por: Jiang, Ze-Bo, et al.
Publicado: (2020) -
Potential prognostic factors in progression-free survival for patients with cervical cancer
por: Chen, Hui-Hui, et al.
Publicado: (2021)